ISIN | LU2488092995 |
---|---|
Valorennummer | 119403768 |
Bloomberg Global ID | |
Fondsname | Kieger Sustainable Healthcare Fund Class B USD Accumulating |
Fondsanbieter |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Telefon: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
Fondsanbieter | Kieger AG |
Vertreter in der Schweiz |
ACOLIN Fund Services AG Zürich Telefon: +41 44 396 96 96 |
Distributor(en) | |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
Investment-Strategie *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager. |
Besonderheiten |
Aktueller Preis * | 105.36 USD | 18.08.2025 |
---|---|---|
Vorheriger Preis * | 103.59 USD | 14.08.2025 |
52 Wochen Hoch * | 121.94 USD | 30.08.2024 |
52 Wochen Tief * | 100.18 USD | 07.08.2025 |
NAV * | 105.36 USD | 18.08.2025 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 213'304'745 | |
Anteilsklassevermögen *** | 1'129'771 | |
Trading Information SIX |
YTD-Performance | -0.25% |
31.12.2024 - 18.08.2025
31.12.2024 18.08.2025 |
---|---|---|
YTD-Performance (in CHF) | -11.29% |
31.12.2024 - 18.08.2025
31.12.2024 18.08.2025 |
1 Monat | +1.36% |
18.07.2025 - 18.08.2025
18.07.2025 18.08.2025 |
3 Monate | -0.69% |
19.05.2025 - 18.08.2025
19.05.2025 18.08.2025 |
6 Monate | -6.12% |
18.02.2025 - 18.08.2025
18.02.2025 18.08.2025 |
1 Jahr | -11.61% |
19.08.2024 - 18.08.2025
19.08.2024 18.08.2025 |
2 Jahre | +5.72% |
18.08.2023 - 18.08.2025
18.08.2023 18.08.2025 |
3 Jahre | +5.36% |
05.07.2023 - 18.08.2025
05.07.2023 18.08.2025 |
5 Jahre | - | - |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Abbott Laboratories | 5.91% | |
---|---|---|
Eli Lilly and Co | 5.61% | |
AstraZeneca PLC | 5.57% | |
Novartis AG Registered Shares | 5.48% | |
Roche Holding AG | 4.86% | |
Vertex Pharmaceuticals Inc | 4.12% | |
Boston Scientific Corp | 3.96% | |
Intuitive Surgical Inc | 3.76% | |
Novo Nordisk AS Class B | 3.63% | |
UnitedHealth Group Inc | 3.47% | |
Letzte Daten-Aktualisierung | 31.05.2025 |
TER *** | 0.99% |
---|---|
Datum TER *** | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.85% |
Ongoing Charges *** | 0.99% |
SRRI ***
|
|
Datum SRRI *** | 31.07.2025 |